Insider · CIK 0001377202

Sharp Shalini

CIK 0001377202 Name as filed on the most recent filing

Filed as Sharp Shalini (43)

69 transaction lines · from 43 filings · filed 2007-03-14 to 2024-05-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

69 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-01-30 P, Open-market purchase Ultragenyx Pharmaceutical Inc.RARE 94,500, acquired Open Form 4 filing 0001209191-14-006665
2013-01-30 S, Open-market sale Agenus IncAGEN 1,256, disposed Open Form 4 filing 0001288123-13-000011
2012-10-31 S, Open-market sale Agenus IncAGEN 1,267, disposed Open Form 4 filing 0001288123-12-000075
2012-08-29 S, Open-market sale Agenus IncAGEN 1,336, disposed Open Form 4 filing 0001288123-12-000058
2011-12-28 S, Open-market sale Agenus IncAGEN 3,576, disposed Open Form 4 filing 0001288123-11-000096
2011-12-27 S, Open-market sale Agenus IncAGEN 6,105, disposed Open Form 4 filing 0001288123-11-000096
2011-12-23 S, Open-market sale Agenus IncAGEN 1,747, disposed Open Form 4 filing 0001288123-11-000092
2011-12-22 S, Open-market sale Agenus IncAGEN 3,391, disposed Open Form 4 filing 0001288123-11-000092
2011-12-21 S, Open-market sale Agenus IncAGEN 6,909, disposed Open Form 4 filing 0001288123-11-000092
2010-10-28 S, Open-market sale Antigenics Inc /DE/AGEN 1,440, disposed Open Form 4 filing 0001288123-10-000072
2010-09-14 S, Open-market sale Antigenics Inc /DE/AGEN 1,824, disposed Open Form 4 filing 0001288123-10-000063
2010-07-27 S, Open-market sale Antigenics Inc /DE/AGEN 1,408, disposed Open Form 4 filing 0001288123-10-000056
2010-04-27 S, Open-market sale Antigenics Inc /DE/AGEN 2,262, disposed Open Form 4 filing 0001288123-10-000030
2010-01-20 S, Open-market sale Antigenics Inc /DE/AGEN 54,488, disposed Open Form 4 filing 0001288123-10-000010
2010-01-20 S, Open-market sale Antigenics Inc /DE/AGEN 54,488, acquired Open Form 4 filing 0001288123-10-000006
2009-07-16 S, Open-market sale Antigenics Inc /DE/AGEN 52,625, disposed Open Form 4 filing 0001288123-09-000048
2009-07-15 S, Open-market sale Antigenics Inc /DE/AGEN 23,397, disposed Open Form 4 filing 0001288123-09-000048
2007-03-13 P, Open-market purchase Antigenics Inc /DE/AGEN 9,836, acquired Open Form 4 filing 0001288123-07-000012
2007-03-12 P, Open-market purchase Antigenics Inc /DE/AGEN 9,736, acquired Open Form 4 filing 0001288123-07-000012

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 66
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Sharp Shalini, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001377202

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.